Human hematopoietic CD34+ progenitor cells induce natural killer cell alloresponses via NKG2D activation

Human CD34+ cells cross-interact with allogeneic T lymphocytes. In this study we addressed the interaction between CD34+ cells and allogeneic natural killer (NK) cells. Purified NK cells were cultured with allogeneic KIR-permissive CD34+ or CD14+ blood cells, obtained from HLA group C homozygous donors, or with high-dose interleukin-2. A cytotoxicity assay was used to test the ability of NK cells to lyse NK-sensitive K562 or NK-resistant Daudi cells. Cytofluorometric assays were employed to assess cell phenotype and cytokine release. CD34+ cells induced greater lysis of K562 (p = 0.02) and Daudi cells (p = 0.01) than monocytes. CD34 cell stimulation resulted in upregulation of CD69 and CD25 on NK cells and in the production of interferon γ and tumor necrosis factor α. NK activation by CD34+ cells was inhibited by an anti-NKG2D antibody. However, NKG2D ligands such as MIC (MHC class I chain)-A/B and ULBP (UL16 binding protein)-1/3 were not detected on CD34+ cells. Cross-talk between NK and CD34+ cells also induced the upregulation of CD40 and CD86 co-stimulatory molecules on CD34+ cells. Our study indicates a direct NKG2D-dependent stimulatory effect of human CD34+ cells on allogeneic NK cells. These findings may be relevant to the NK-mediated rejection effect in HLA-mismatched hematopoietic stem cell transplantation.